Results 131 to 140 of about 1,221,619 (355)

細胞周期制御遺伝子ZAC/PLAGL1のインプリント発現 : 新生児一過性糖尿病の候補遺伝子の単離 [PDF]

open access: yes, 2000
Joint authors: Hannah Judson ... [et al.]Offprint. Originally published in: Human Molecular Genetics, v. 9, no. 3, pp. 453-460, 2000Includes supplementary treatisesThesis (Ph. D. in Medical Sciences)--University of Tsukuba, (B), no.
Kamiya Mamoru, 神谷 守
core  

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Editorial: The Importance of Genetic Literacy and Education in Medicine

open access: yesFrontiers in Genetics, 2022
Nina Pereza   +6 more
doaj   +1 more source

Medical genetics: Development of ethical dimensionsin clinical practice and research [PDF]

open access: yes, 2016
A Witness Seminar on the emergence of complex ethical issues in clinical genetics practice, the evolution of these issues over several decades of advances in medical genetics research and social change, and the professionalization of this field.
Jones, EM, Tansey, EM
core  

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Genetic-Metabolic News [PDF]

open access: yes, 1973
This is the first in a series of newsletters designed to inform the Virginia medical community of recent advances in the area of genetics and metabolism and to provide information regarding a variety of services that are available at the Medical College ...

core   +1 more source

Home - About - Disclaimer - Privacy